| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 17 |
| 1 | INTERFERON BETA-1A | 15 |
| 2 | NATALIZUMAB | 14 |
| 3 | IBUPROFEN | 13 |
| 4 | PREDNISONE | 12 |
| 5 | ABATACEPT | 11 |
| 6 | ACETAMINOPHEN | 11 |
| 7 | METHOTREXATE SODIUM | 11 |
| 8 | ETANERCEPT | 10 |
| 9 | IBUPFROFEN | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBRITUMOMAB TIUXETAN | 5 | 0.0033 |
| 1 | LOTEPREDNOL ETABONATE AND TOBRAMYCIN | 1 | 0.0025 |
| 2 | ZANAMIVIR | 5 | 0.0020 |
| 3 | TEZEPELUMAB-EKKO | 8 | 0.0012 |
| 4 | FERRIC DERISOMALTOSE | 1 | 0.0007 |
| 5 | CEFOXITIN SODIUM | 1 | 0.0007 |
| 6 | NIZATIDINE | 1 | 0.0007 |
| 7 | ALPHA1-PROTEINASE INHIBITOR (HUMAN) | 1 | 0.0005 |
| 8 | GLYCOPYRROLATE AND FORMOTEROL FUMARATE | 1 | 0.0005 |
| 9 | POLATUZUMAB VEDOTIN | 5 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 32 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 23 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 18 |
| 3 | Interferon beta [EPC] | 15 |
| 4 | Integrin Receptor Antagonist [EPC] | 14 |
| 5 | Vitamin C [EPC] | 14 |
| 6 | Proton Pump Inhibitor [EPC] | 11 |
| 7 | Selective T Cell Costimulation Modulator [EPC] | 11 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 10 |
| 9 | Vitamin B12 [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Neuraminidase Inhibitor [EPC] | 5 | 0.0020 |
| 1 | Thymic Stromal Lymphopoietin Blocker [EPC] | 8 | 0.0012 |
| 2 | Human alpha-1 Proteinase Inhibitor [EPC] | 1 | 0.0002 |
| 3 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 4 | Antiparasitic [EPC] | 1 | 0.0002 |
| 5 | Pediculicide [EPC] | 1 | 0.0002 |
| 6 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 7 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 8 | Integrin Receptor Antagonist [EPC] | 14 | 0.0002 |
| 9 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 2 | 0.0001 |